Ittai Harel
board of director
cardiology
Teva pharmaceutical
Israel
Biography
Ittai Harel is a General Partner of Pitango. Before joining Pitango, Mr. Harel headed up Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) and served as Executive Vice President at IDGene Pharmaceuticals. He also served as head of business development at IDEXX Laboratories (NASDAQ: IDXX). Mr. Harel holds a B.Sc. in Chemical Engineering and Biotechnology from Ben Gurion University, and an MBA from the MIT Sloan School of Management. Ittai Harel is a General Partner of Pitango. Before joining Pitango, Mr. Harel headed up Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) and served as Executive Vice President at IDGene Pharmaceuticals. He also served as head of business development at IDEXX Laboratories (NASDAQ: IDXX). Mr. Harel holds a B.Sc. in Chemical Engineering and Biotechnology from Ben Gurion University, and an MBA from the MIT Sloan School of Management.
Research Interest
pharmaceutical industry.
